Clinical Trials Browser

Interventional × Neoplasms, Unknown Primary × pembrolizumab × Clear all

Carcinoma, Neoplasms, Neoplasms, Unknown Primary

NCT02721732 2026-01-29

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Adrenal Cortex Neoplasms, Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms, Unknown Primary, Paraganglioma, Penile Neoplasms, Pheochromocytoma, Carcinoma, Small Cell, Vascular Neoplasms

NCT03391973 2025-04-25

CUP

Phase 2 Active not recruiting

26 enrolled

Tumor-Agnostic

Neoplasms, Unknown Primary

Clinical Trials

CUPem

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

CUP